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Prior to being released from the infected cell,
intracellular enveloped vaccinia virus particles
are transported from their perinuclear assembly
site to the plasma membrane along microtu-
bules by the motor kinesin-1. After fusion with
the plasma membrane, stimulation of actin tails
beneath extracellular virus particles acts to en-
hance cell-to-cell virus spread. However, we
lackmolecular understanding of events that oc-
cur at the cell periphery just before and during
the liberation of virus particles. Using live cell
imaging, we show that virus particles move in
the cell cortex, independently of actin tail for-
mation. These cortical movements and the sub-
sequent release of virus particles, which are
both actin dependent, require F11L-mediated
inhibition of RhoA-mDia signaling. We suggest
that the exit of vaccinia virus from infected cells
has strong parallels to exocytosis, as it is
dependent on the assembly and organization
of actin in the cell cortex.
INTRODUCTION
Vaccinia virus, a close relative of Variola virus, the causa-
tive agent of smallpox, is a large double-stranded DNA
virus that undergoes a complex replication cycle in the
cytoplasm of the infected cell (Harrison et al., 2004; Smith
et al., 2003). Replication, which occurs in viral factories
anchored at or near the microtubule-organizing center, re-
sults in the formation of two types of cytoplasmic virus
particles, the intracellular mature virus (IMV) and the intra-
cellular enveloped virus (IEV) (Harrison et al., 2004; Smith
et al., 2003). IMV move throughout the cytoplasm in a bidi-
rectional manner at speeds up to 3 mm$s1, consistent
with a microtubule-based transport mechanism (Ward,
2005). IEV are formed when IMV are wrapped by mem-
brane cisternae derived from the trans-Golgi network or
endosomal compartments containing a subset of integral
viral membrane proteins (Harrison et al., 2004; Smith et al.,
2003). IEV recruit the plus end-directed microtubule motor
kinesin-1 (conventional kinesin) and are subsequently
transported to the plasma membrane on microtubules in
a saltatory fashion at speeds of up to 3 mm$s1 (GeadaCellet al., 2001; Hollinshead et al., 2001; Rietdorf et al.,
2001; Ward and Moss, 2001a, 2001b). Fusion of the IEV
with the plasma membrane results in the formation of
the extracellular cell-associated enveloped virus (CEV)
(Harrison et al., 2004; Smith et al., 2003). CEV that remain
attached to the cell are able to induce an outside-in signal-
ing cascade to locally activate Src and Abl family kinases
(Frischknecht et al., 1999; Newsome et al., 2004, 2006;
Reeves et al., 2005). This activation results in the tyrosine
phosphorylation of A36R (Frischknecht et al., 1999; News-
ome et al., 2004, 2006), an integral vaccinia membrane
protein that becomes localized in the plasma membrane
beneath CEV (Ro¨ttger et al., 1999; Smith et al., 2002; van
Eijl et al., 2000). Phosphorylation of A36R facilitates the
release of kinesin-1 (Newsome et al., 2004), and the sub-
sequent recruitment of a signaling complex consisting of
Grb2, Nck, WIP (WASP-interacting protein), and N-WASP
(Frischknecht et al., 1999; Moreau et al., 2000; Scaplehorn
et al., 2002; Snapper et al., 2001; Zettl and Way, 2002).
The recruitment of N-WASP stimulates the actin-nucleat-
ing activity of the Arp2/3 complex, resulting in actin tail
formation beneath the CEV (Frischknecht and Way, 2001).
The stimulation of actin tails then acts to enhance cell-
to-cell spread of the virus (Cudmore et al., 1995, 1996;
Hollinshead et al., 2001; Ward and Moss, 2001a).
It has been calculated that an IEV particle would take 5.7
hr to move 10 mm in the cytoplasm of an infected cell, in
the absence of an active transport mechanism (Sodeik,
2000). Clearly, cell-to-cell spread of vaccinia would be
extremely inefficient if the virus was only dependent on dif-
fusion. Fortuitously for the virus, it has evolved the ability
to use both microtubule- and actin-based motility during
its exit from the infected cell. Although actin-based motil-
ity provides an extra advantage to the virus, it is microtu-
bule-based transport that plays the most important role
during the spread of infection. In the absence of microtu-
bule transport, IEV would only be released when the cell
undergoes lysis or when a virus particle encounters the
plasma membrane due to a diffusion-driven process. Mi-
crotubule-based transport thus ensures that IEV particles
are efficiently delivered to the plasma membrane, where
they are ultimately released from the infected cell.
We have shown that vaccinia not only uses the micro-
tubule cytoskeleton for its transport but also stimulates in-
creased microtubule dynamics during infection (Arakawa
et al., 2007 [this issue of Cell Host & Microbe]). Vaccinia
achieves these changes through the action of F11L, which
binds to RhoA and blocks its ability to signal to mDiaHost & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 227
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Vaccinia Exit Involves Cortical Actin RemodelingFigure 1. Stabilizing Microtubules Inhibits Virus Release
(A) Immunofluorescence images of the actin cytoskeleton, extracellular cell-associated enveloped virus (CEV = B5R), or intracellular and extracellular
enveloped virus (IEV + CEV = F13L) particles in cells infected with WR for 10 hr after treatment with nocodazole or paclitaxel for the previous 2 hr.
(B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in cells treated with nocodazole or paclitaxel.228 Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc.
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Vaccinia Exit Involves Cortical Actin Remodeling(Arakawa et al., 2007; Valderrama et al., 2006). Infection
also increases the targeting of microtubules to the cell pe-
riphery, suggestive of possible changes in the cell cortex.
In this paper we sought to examine if changes in peripheral
microtubule dynamics and their cortical targeting contrib-
ute to the exit of vaccinia from infected cells. Our observa-
tions have uncovered a role for RhoA-mDia signaling in the
regulation of cortical actin and an actin-dependent move-
ment of virus particles, which is likely to be a myosin-
driven event, in the cell cortex prior to their release.
RESULTS
Microtubule Dynamics Promotes Release of Virus
from Infected Cells
To test whether changes in microtubule dynamics might
contribute to the spread of infection, we examined the
effect of nocodazole and paclitaxel on vaccinia actin tail
formation. We found that depolymerization of micro-
tubules by 2 hr treatment with nocodazole, at 8 hr postin-
fection with Western Reserve (WR), results in a dramatic
reduction in the number of actin tails and extracellular
virus particles (CEV), indicative of a lack of IEV transport
to the plasma membrane (Figures 1A–1C), as previously
reported (Geada et al., 2001; Hollinshead et al., 2001;
Ward and Moss, 2001a, 2001b). Consistent with these ob-
servations, reinfection plaque assays demonstrated that
there was a corresponding decrease (>95%) in the num-
ber of infectious virus particles released into the media
of nocodazole-treated cells (Figure 1D). Stabilization of
microtubules with paclitaxel also resulted in a significant
reduction in the number of WR-infected cells with actin
tails and loss of extracellular CEV (Figures 1A–1C). There
was also a corresponding 60% reduction in the number
of infectious virus particles released from paclitaxel-
treated cells (Figure 1D). The effects of nocodazole and
paclitaxel on virus release are not dependent on actin
tail formation during WR infection. Treatment with either
drug also reduced the number of extracellular CEV and in-
fectious virus particles released into the media from cells
infected with the recombinant virus strain A36R-YdF,
which is unable to induce actin tails (Figures 1C and 1D).
The effects of nocodazole on CEV formation and virus
release are readily explained by a lack of microtubule-
dependent transport during both the formation of IEV
and their subsequent transport to the cell periphery. A
similar defect in microtubule-dependent transport of IEV
to the plasma membrane could also account for the
effects of paclitaxel treatment if kinesin-1 is unable to
move on stabilized microtubules. However, this does not
appear to be the case, as video analysis reveals that
YFP-tagged IEV are still transported along microtubules
in the presence of paclitaxel (Figure 2A; Movie S1 in theCellSupplemental Data available with this article online). It
was noticeable, however, that the characteristic accumu-
lation of virus particles at the edge of infected cells was
absent in paclitaxel-treated cells (Figure 2A; Movie S1).
Focusing on the bottom of paclitaxel-treated cells reveals
that IEV particles are dispersed throughout the cell and
also had great difficulty in approaching to within 4 mm
of the plasma membrane at the edge of the cell (Figure 2A).
The region immediately beneath the plasma membrane,
which is known as the cell cortex, consists of a dense
meshwork of actin filaments. One possible explanation
for the effects of paclitaxel on intracellular virus distribution
is that stabilization of microtubule cytoskeleton results in
the reorganization of the actin in the cell cortex, which
then acts as a barrier to prevent the virus from reaching
the plasma membrane. To explore this hypothesis, we
examined whether modulation of actin dynamics by the
addition of Latrunculin B would rescue the effects of pac-
litaxel on virus release. We found that inhibition of actin
polymerization with low concentrations of Latrunculin B
(0.1 mM) could partially rescue the release of infectious
virus particles from paclitaxel-treated cells (Figure 2B).
Our observations are consistent with the hypothesis that
the organization of cortical actin regulates the ability of
the virus to reach the plasma membrane during its release.
Virus Release Involves an Actin-Dependent Event
in the Cell Cortex
It is well established that the actin cytoskeleton plays an
important role at multiple stages during exocytosis. We
therefore wondered whether the release of virus particles
at the plasma membrane is also dependent on actin, given
they are a similar dimension to secretory granules. We
found that a 2 hr treatment with a low (0.1 mM) concentra-
tion of Latrunculin B at 8 hr postinfection did not affect the
number of WR-infected cells with actin tails or inhibit re-
lease of infectious virus particles into the media (Fig-
ure 2C). Indeed, video analysis and quantitative analysis
of peripheral virus distribution reveals that this low con-
centration of Latrunculin B actually stimulates movement
of virus particles in the cell periphery toward the plasma
membrane (Figures 2D and 2E; Movie S2). In contrast, a
similar treatment with high (1 mM) concentration of Latrun-
culin B was found to reduce the number of actin tails and
the release of infectious virus particles (Figure 2C). Treat-
ment of WR-infected cells with Cytochalasin D, which, in
contrast to Latrunculin B, can cap the fast-growing end
of actin filaments, in addition to sequestering actin mono-
mers, was found to have more potent effects on the
inhibition of actin tails and virus release (Figure 2C). Our
observations indicate that virus release is dependent on
the organization and dynamics of the actin cytoskeleton
in the cell cortex.(C) Representative immunofluorescence images of cells infected with the A36R-YdF strain of vaccinia, which is deficient in actin tail formation, reveal
that treatment with nocodazole or paclitaxel results in loss of extracellular virus particles.
(D) Quantitative analyses of the number of infectious particles released from WR- and A36R-YdF-infected cells treated with the indicated drug.
Error bars represent SEM; ***p < 0.0001. All scale bars, 20 mm.Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 229
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Vaccinia Exit Involves Cortical Actin Remodelingre 2. Actin Cytoskeleton Organization Modulates Virus Release
icrotubule-dependent movement of intracellular enveloped virus (IEV) visualized with A36R-YdF-YFP with or without paclitaxel treatment.
le-cell panel shows IEV virus particle distribution and tracks over 56 s, while the smaller panels represent movie stills from the highlighted
(see Movie S1).
uantitative analyses of the number of infectious particles released from WR-infected cells treated with the indicated drug.
uantitative analyses of the number of infectious particles released from WR-infected cells treated with the indicated drug (left). Quantitative
yses of the actin tail positive cell rate and the number of actin tails in cells treated with the indicated drug (middle, right).
ime-lapse images of the periphery of a cell infected with the A36R-YdF-YFP virus reveal that addition of 0.1 mM Latrunculin B but not DMSO
ulates rapid movement of IEV virus particles to the plasma membrane (see Movie S2).
nalyses of the number of virus particles 0–4 and 4–10 mm from the cell margin after a 5 min treatment with 0.1 mM Latrunculin B or DMSO in
-YdF-infected cells.
r bars represent SEM; ***p < 0.0001. All scale bars, 20 mm.Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc.
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Vaccinia Exit Involves Cortical Actin RemodelingActin-Dependent Movement of Virus Particles
in the Cell Cortex
To obtain more insights into the nature of virus particle
movements occurring in the cell periphery, we performed
video analysis at a higher sampling frequency on cells in-
fected with the A36R-YdF virus, which cannot make actin
tails. In the absence of drug treatments, we found that
there were two distinct types of virus movement in addi-
tion to static virus particles (Figure 3A; Movies S3–S5).
The first type of movement, which tended to occur over
longer distances and in linear fashion, had an average
speed of 1.06 ± 0.24 mm/s (n = 87), consistent with micro-
tubule-based transport. The second form of motility, which
was more random and tended to occur closer to the edge
of the cell, had an average speed of 0.35 ± 0.1 mm/s (n =
301). When cells were treated with paclitaxel, there was
a noticeable reduction in the second form of motility (Fig-
ure 3A; Movie S3). This paclitaxel-mediated inhibition of
movement could be reversed by addition of low concen-
trations of Latrunculin B (Figure 3A; Movie S3). Consistent
with these live observations, we found that low concentra-
tions of Latrunculin B could partially rescue the effects of
paclitaxel on the distribution of virus particles in the cell
periphery (Figure 3B). The speed and behavior of this
second form of virus motility is highly suggestive of an
actin-based transport. To confirm this hypothesis, we ex-
amined the effect of modulating actin dynamics on virus
particle movements in the cell periphery. We found that
depolymerization or stabilization of actin filaments with
Cytochalashin D or Jaspaklinolide, respectively, results
in an increase in the number of static particles and reduc-
tion in the number of the slow random virus movements
(Figure 3C; Movies S4 and S5).
The observation that addition of paclitaxel inhibits actin-
dependent virus movements in the cell periphery suggests
that microtubule dynamics is linked to regulation of corti-
cal actin. This is not unexpected given the intimate and
reciprocal relationship between microtubule and actin
cytoskeletons. Live imaging and quantitative analysis on
infected cells expressing YFP-actin reveal that addition
of paclitaxel stimulates actin polymerization in cell cortex
(Figures 3D and 3E). The ability of paclitaxel to stimulate
actin polymerization in the cortex of infected cells is highly
suggestive of RhoA activation. Quantitative western blot
analysis of Rhotekin-pull-down assays on extracts from
WR-infected cells treated with paclitaxel confirmed that
stabilization of microtubules increases the level of GTP-
bound Rho at 8 hr postinfection (Figure 3F). Our observa-
tions suggest that the organization of cortical actin regu-
lates an actin-dependent transport step in the cell cortex,
which is required for virus particles to reach the plasma
membrane.
Loss of RhoA Signaling Facilitates Virus Release
Given the ability of paclitaxel to activate RhoA and stimu-
late peripheral actin polymerization, we investigated
whether RhoA signaling also regulates virus release. We
found that expression of constitutively active RhoA-V14,
but not dominant-negative RhoA-N19, at 8 hr postinfec-Celltion dramatically reduces the number of CEV and their
associated actin tails in WR-infected cells (Figures 4A
and 4B). Reinfection assays confirmed that expression
of RhoA-V14 also reduces the release of infectious virus
particles (Figure 4C). Consistent with our earlier observa-
tions, we found that the effect of RhoA-V14 expression on
virus release could be reversed by treating infected cells
with low concentrations of Latrunculin B (Figure 4C). Like-
wise, expressing dominant-negative RhoA-N19 neutral-
ized the effects of paclitaxel treatment on virus release
(Figure 4C). Our observations suggest that RhoA signaling
plays an important role in regulating the organization of the
actin cytoskeleton during virus release.
F11L-Mediated Inhibition of RhoA Enhances
Virus Release
Our observations suggest that RhoA signaling acts to
inhibit virus release by stimulating actin polymerization in
the cell cortex. However, during the course of a normal
infection, the viral protein F11L binds to RhoA to inhibit
its downstream signaling (Arakawa et al., 2007; Valder-
rama et al., 2006). Our previous observations have dem-
onstrated that F11L is required for efficient virus particle
assembly. Consequently, to examine if F11L-mediated
inhibition of RhoA signaling is required for virus release,
we examined the consequences of overexpressing an
F11L mutant (F11L-VK) that is unable to bind RhoA. We
found that overexpression of F11L-VK, at 8 hr postinfec-
tion, results in a dramatic reduction in the number of extra-
cellular virus particles (CEV) and actin tails in WR-infected
cells (Figures 5A–5C). There was also a corresponding re-
duction in the number of infectious virus particles released
into the media (Figure 5D). The effects of F11L-VK on virus
release could be rescued by inhibiting RhoA signaling with
TAT-C3. F11L-VK mutant appears to be acting as a dom-
inant negative to prevent the F11L-mediated inhibition of
RhoA signaling during vaccinia infection. Our previous ob-
servations have shown that F11L binds RhoA in a similar
fashion to ROCK (Valderrama et al., 2006), suggesting
that F11L may also function as a dimer. We therefore per-
formed pull-down assays to examine if F11L can interact
with itself. We found that GST-tagged F11L and F11L-VK
were equally effective pulling down endogenous F11L
from WR-infected cells (Figure 5E). We believe that the
formation of F11L and F11L-VK complexes that are unable
to inhibit RhoA signaling is likely to account for the domi-
nant-negative effect of F11L-VK overexpression on virus
release.
RhoA Signaling to mDia Regulates Cortical Actin
and Virus Release
Previous studies have established a role for Myosin II dur-
ing exocytosis. As Myosin II is downstream of RhoA-ROCK
signaling, we wondered whether ROCK participates in
regulating cortical actin during virus release. We found
that the formation of actin tails and release of infectious
virus particles from paclitaxel-treated cells is rescued by
inhibiting RhoA signaling with TAT-C3 exoenzyme (Figures
6A–6C). In contrast, inhibition of ROCK with Y-27632 didHost & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 231
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Vaccinia Exit Involves Cortical Actin RemodelingFigure 3. Actin-Dependent Movement of Virus Particles in the Cell Periphery
(A) Movement of intracellular enveloped virus (IEV) visualized with A36R-YdF-YFP in the cell cortex before and after first paclitaxel addition and
second 0.1 mM Latrunculin B. Smaller panels represent movie stills from the highlighted area in main cell. Color-coded tracks of the movements
of virus particles over 26 s for each drug regime are indicated above each movie still (see Movie S3).
(B) Quantitative analyses of the number of virus particles 0–4 and 4–10 mm from the cell margin after treatment with DMSO for 30 min, paclitaxel for
30 min, or 0.1 mM Latrunculin B (5 min) following 30 min incubation in paclitaxel in A36R-YdF-infected cells.
(C) Color-coded tracks of IEV particle movements in the cell cortex over 26 s before and after the indicated drug (see Movies S4 and S5).
(D) Confocal laser scanning images of actin cytoskeleton at the bottom of WR-infected cells expressing YFP-actin confirm that treatment with
paclitaxel stimulates actin polymerization in the cell periphery.
(E) Quantitative analysis of the relative intensity of cortical actin in WR-infected cells expressing YFP-actin treated with DMSO or paclitaxel.
(F) Immunoblot and quantitative analysis of Rho activity in WR-infected cells treated with paclitaxel.
Error bars represent SEM. All scale bars, 20 mm.232 Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc.
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Vaccinia Exit Involves Cortical Actin RemodelingFigure 4. RhoA Signaling Inhibits Virus Release by Stimulating Actin Polymerization
(A) Immunofluorescence images of extracellular cell-associated enveloped virus (CEV = B5R) or intracellular and extracellular enveloped virus
(IEV + CEV = F13L) particles in WR-infected cells expressing GFP-tagged RhoA V14 and RhoA N19 and treated with 0.1 mM Latrunculin B.
(B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing the indicated GFP-tagged
protein.
(C) Quantitative analyses of the number of infectious virus particles released from WR-infected cells expressing the indicated protein and treated with
the indicated drugs.
Error bars represent SEM; ***p < 0.0001.not rescue the effects of paclitaxel on WR-infected cells
(Figures 6A–6C). Given the absence of an effect of Y-
27632 on paclitaxel-treated cells, we examined whether
expression of active mDia1 (mDia1 DN3) might inhibit
release of infectious virus particles. We found that expres-
sion of the active form of mDia1 but not ROCK1 (ROCK1
D3) reduced the number of extracellular virus particles
and actin tails in WR-infected cells (Figures 7A and 7B).Cell HActive mDia1 also reduced the number of infectious parti-
cles released into the media (Figure 7C). The effect of ac-
tive mDia1 on virus release could be rescued by treating in-
fected cells with low concentrations of Latrunculin B
(Figure 7C). To obtain further insights into the role of
RhoA-mDia signaling during virus release, we performed
video analysis on infected cells expressing active RhoA
or mDia1 at 8 hr postinfection (Figure 7D; Movie S6). Inost & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 233
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Vaccinia Exit Involves Cortical Actin RemodelingFigure 5. An Interaction of F11L with RhoA Is Required to Promote Virus Release
(A) Representative immunofluorescence images of the actin cytoskeleton, CEV (B5R), or IEV and CEV (F13L) particles in WR-infected cells expressing
GFP-F11L-VK, which cannot bind RhoA, with or without TAT-C3 treatment.
(B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing GFP-F11L-VK with or without
TAT-C3 treatment.
(C) Immunofluorescence images ofCEV (B5R)and IEV + CEV (F13L) inWR-infected cellsexpressing GFP-F11L-VK in the presenceor absence ofTAT-C3.
(D) Quantitative analyses of the number of infectious particles released from WR-infected cells expressing GFP-F11L-VK in the presence or absence
of TAT-C3.
(E) Immunoblot analyses of pull-down assays reveal that GST-tagged F11L or F11L-VK is able to interact with endogenous F11L during WR infection.
Error bars represent SEM; **p < 0.001, ***p < 0.0001.contrast to controls, we found that virus particles did not
accumulate at the edge of cells expressing active RhoA
or mDia1. It was also apparent that virus particles in the234 Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elseviercell periphery were also largely static and did not undergo
slow actin-dependent movements (Figure 7D). Taken
together, our observations suggest that F11L-mediatedInc.
Cell Host & Microbe
Vaccinia Exit Involves Cortical Actin RemodelingFigure 6. ROCK Is Not Required for
Microtubule-Dependent Virus Release
(A) Immunofluorescence images of the actin
cytoskeleton, CEV (B5R), or IEV and CEV
(F13L) particles in WR-infected cells treated
with the indicated drugs or TAT-C3.
(B) Quantitative analyses of the actin tail posi-
tive cell rate and the number of actin tails in
WR-infected cells in the various treatments.
(C) Quantitative analysis of the number of infec-
tious particles released from WR-infected cells
treated with the indicated drugs.
Error bars represent SEM; ***p < 0.0001.inhibition of RhoA-mDia signaling leads to changes in or-
ganization of actin in the cell cortex, which acts to facilitate
virus release (Figure 7E).
DISCUSSION
The Actin Cortex Regulates Virus Release
The ability of virus particles to reach the cell periphery and
fuse with the plasma membrane is critical for the cell-
to-cell spread of vaccinia virus. It is therefore not surpris-
ing that treatment with nocodazole reduced accumulation
of particles in cell periphery, actin tail formation, and re-
lease of infectious virus particles given the importance of
microtubules in IEV transport to the plasma membrane
(Geada et al., 2001; Hollinshead et al., 2001; Rietdorf
et al., 2001; Ward and Moss, 2001a, 2001b). We did not,
however, expect to obtain similar results when microtu-
bules were stabilized by paclitaxel. The effects of pacli-
taxel are not related to microtubule-dependent transport,
as IEV moved toward the cell periphery at speeds indistin-
guishable from untreated cells (data not shown). This is
consistent with recent observations demonstrating that
stabilization of microtubules via acetylation promotesCelrather than inhibits kinesin-1 binding and cargo transport
(Reed et al., 2006). Instead, our observations indicate
that the effects of paclitaxel on virus release are related
to its ability to stimulate RhoA-dependent actin polymeri-
zation in the cell cortex.
The cell cortex immediately beneath the plasma mem-
brane consists of an extremely dense arrangement of
actin filaments. These actin filaments are constantly being
remodeled in response to numerous signaling pathways
to accommodate the cells ever-changing needs. The or-
ganization and dynamics of actin in the cell cortex plays
an important role in the normal functioning of the cell, as
it helps to maintain the cell shape and provides the driving
force for cell motility. Remodeling of cortical actin is also
essential for endocytosis and exocytosis (Eitzen, 2003;
Engqvist-Goldstein and Drubin, 2003; Malacombe et al.,
2006; Qualmann and Kessels, 2002). Notwithstanding its
importance in membrane trafficking, cortical actin actually
represents a significant barrier to exocytosis, as it pre-
vents vesicles and secretory granules from reaching and
fusing with the plasma membrane.
Vaccinia virus particles are of similar dimension to secre-
tory granules (Cyrklaff et al., 2005). It is therefore notl Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 235
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Vaccinia Exit Involves Cortical Actin RemodelingFigure 7. mDia-Mediated Actin Polymerization Inhibits Virus Particle Release
(A) Immunofluorescence images of the actin cytoskeleton, CEV (B5R), or IEV and CEV (F13L) particles in WR-infected cells expressing GFP-tagged
active forms of mDia1 (mDia1 DN3) and ROCK1 (ROCK1 D3), in the presence or absence of 0.1 mM Latrunculin B.
(B) Quantitative analyses of the actin tail positive cell rate and the number of actin tails in WR-infected cells expressing mDia1 DN3 and ROCK1 D3.
(C) Quantitative analyses of the number of infectious particles released from WR-infected cells expressing the indicated GFP-tagged protein in the
presence or absence of 0.1 mM Latrunculin B.
(D) Movement of IEV particles in cells infected with A36R-YdF-YFP and expressing mDia1 DN3 and RhoA V14. Smaller panels represent movie stills
from the highlighted area in main cell. Color-coded tracks of the movements of virus particles over 26 s for each drug regime are indicated above each
movie still (Movie S6).
(E) Schematic representation of F11L-mediated inhibition of RhoA-mDia signaling, which results in increased microtubules dynamics and changes in
cortical actin that promote virus particle release.
Error bars represent SEM; ***p < 0.0001.236 Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc.
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Vaccinia Exit Involves Cortical Actin Remodelingsurprising that the actin cortex would act to prevent the vi-
rus reaching the plasma membrane prior to release. We
found that low concentrations of Latrunculin B rescued
the inhibitory effects of paclitaxel treatment on virus re-
lease, presumably as the drug reduces the physical barrier,
by inducing changes in the organization of cortical actin.
Low concentrations of Latrunculin B have also been found
to stimulate exocytosis in a variety of cell types (Eitzen,
2003; Malacombe et al., 2006). Low concentrations of
Latrunculin B clearly do not inhibit actin polymerization,
as in WR-infected cells the virus is still able to stimulate for-
mation of actin tails at a similar level to untreated cells. In
contrast, high concentrations (1 mM) of Latrunculin B or
low concentrations (0.1 mM) of Cytochalasin D suppress
both actin tail formation and virus release. The difference
in potency between Latrunculin B and Cytochalasin D, at
low concentrations, reflects their different modes of action.
Both bind actin monomers to reduce the pool of polymeri-
zation-competent actin (Coue et al., 1987). However, only
Cytochalasin D can bind directly to the faster growing or
barbed end of actin filaments to inhibit their elongation
(Sampath and Pollard, 1991). The simplest explanation
for our observations is that a dynamic actin cytoskeleton
is required for virus release. The question is at what stage
during virus release dynamic actin cytoskeleton is involved.
What Drives Peripheral Virus Movement?
During secretory granule exocytosis, the actin cortex is
thought to undergo local remodeling to allow myosin mo-
tors to transport their associated cargoes to the plasma
membrane (Soldati and Schliwa, 2006). On reaching the
edge of the cell, the actin cytoskeleton is then thought to
help anchor the secretory granules to the plasma mem-
brane. Finally, actin polymerization drives their fusion
and release (Eitzen, 2003; Malacombe et al., 2006). Given
their size and need for directed transport, it is likely that re-
lated steps are also occurring during release of IEV parti-
cles. Indeed, it has been calculated that it would take over
30 min for an IEV to move 1 mm in the cytoplasm, let alone
in the dense actin cortex (Sodeik, 2000). Our observations
have revealed that IEV particles exhibit two distinct types
of movement in the cell periphery. The first occurs over
longer distances and is linear in nature, consistent with mi-
crotubule-based transport. The average speed (1.06 ±
0.24 mm/s) of this movement agrees well with our previous
observations of IEV moving on microtubules in the cell
body (0.8 ± 0.2 mm/s) (Rietdorf et al., 2001). The second
form of movement, which is considerably slower (0.35 ±
0.1 mm/s) and agrees well with myosin-driven motility,
tends to be more random in nature and occurs closer to
the edge of the cell. Similar types and speeds of move-
ments have also been described for secretory granules
in the cell cortex (Lang et al., 2000; Manneville et al.,
2003; Rudolf et al., 2001).
As observed for secretory granules, we found that the
slow random IEV particle movements in the cell periphery
are inhibited by drug-mediated depolymerization or stabi-
lization of the actin cytoskeleton. The need for a dynamic
actin cytoskeleton may point to these movements beingCell Hdriven by actin polymerization. Indeed, previous observa-
tions have demonstrated that intracellular vesicular traf-
ficking can be driven by Arp2/3-dependent actin poly-
merization in a manner that is analogous to that used
by a number of intracellular pathogens such as Listeria
(Benesch et al., 2002; Kaksonen et al., 2000; Rozelle
et al., 2000; Taunton et al., 2000). However, we do not
think that is the case for vaccinia, as peripheral IEV particle
movements (0.35 ± 0.1 mm/s) are about twice as fast
as the rate at which CEV particles move on actin tails
(0.18 ± 0.05 mm/s) (Rietdorf et al., 2001). In addition, we
have never observed an enrichment of actin on IEV parti-
cles during infections with the A36R-YdF virus, which is
unable to stimulate actin tails.
A number of reports have also demonstrated that
the actin-dependent movement of endosomes involves
RhoB signaling through mDia (Fernandez-Borja et al.,
2005; Gampel et al., 1999; Sandilands et al., 2004; Wallar
et al., 2007). In addition, RhoD has been shown to regulate
the dynamics of Rab5-positive endosomes through mDia
and Src (Gasman et al., 2003). In contrast to these studies,
we have never observed RhoA or mDia on virus particles
moving in the cell periphery or on microtubules. In addi-
tion, we also found that inhibition of RhoA by TAT-C3 ac-
tually stimulates virus release (data not shown). While we
cannot formally rule out a role for RhoA-mDia signaling
during virus trafficking, we believe that our data are
more consistent with a model in which peripheral IEV par-
ticle movements are driven by a myosin motor, combined
with rearrangements of the cortical actin, which are regu-
lated by RhoA-mDia signaling.
RhoA-mDia Signaling Regulates Cortical Actin
Although the actin cortex plays an important role in the life
of a cell, we know surprisingly little at the molecular level
about how its organization and dynamics are controlled.
Previous observations have demonstrated that Cdc42
and Rac play an important role in exocytosis in a variety
of situations and cell types (Eitzen, 2003; Malacombe
et al., 2006; Ridley, 2001; Symons and Rusk, 2003).
More recently, TC10, a Cdc42 homolog, has also been
shown to regulate exocytosis of Glut4 during insulin-stim-
ulated signaling (Kawase et al., 2006; Symons and Rusk,
2003). Our observations in vaccinia-infected cells suggest
that RhoA signaling through mDia plays an important role
in regulating the organization of cortical actin during exo-
cytosis. Our findings are consistent with results demon-
strating that RhoA signaling is required for assembly of
cortical actin after cell blebbing (Charras et al., 2006). Re-
cent observations have also shown that Dia-interacting
protein (DIP) modulates cortical actin during cell blebbing
by interfering with mDia2-mediated actin organization
(Eisenmann et al., 2007). During infection we envisage
that F11L-mediated inhibition of RhoA signaling to mDia
results in changes in the overall organization of cortical ac-
tin that allow the virus to reach the plasma membrane,
probably by a myosin-driven event. These changes may
also explain why microtubules have an increased
tendency to reach the cell periphery during WR infectionost & Microbe 1, 227–240, May 2007 ª2007 Elsevier Inc. 237
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resents a physical barrier to reaching the plasma mem-
brane. Our observations also provide an explanation of
why vaccinia has evolved mechanisms to suppress
RhoA signaling during infection.
Our future studies will be aimed at elucidating which one
of the many myosin motors involved in vesicular traffic
might drive IEV movements in the cell cortex. A detailed
understanding of the temporal and ultrastructural changes
occurring in the actin cortex during infection will also be
required to fully understand exactly how vaccinia escapes
from the cell and whether actin polymerization also facili-
tates fusion of the virus with the plasma membrane.
EXPERIMENTAL PROCEDURES
Infection, Transfection, and Drug Treatments
HeLa cells on fibronectin-coated coverslips or dishes were infected
with WR or the recombinant vaccinia virus strains A36R-YdF (Rietdorf
et al., 2001), A36R-YdF-YFP, and YFP-A3L and processed for immu-
nofluorescence or immunoblot analysis 8–10 hr postinfection as
described previously (Arakawa et al., 2007). Infected cells were also
transfected with pEL expression vectors or treated with drugs (pacli-
taxel [10 mM], nocodazole [10 mg/ml], TAT-C3 exoenzyme [10 mg/ml],
Y-27632 [25 mM], Jasplakinolide [1 mM], Cytochalasin D [0.1–1 mM],
or Latrunculin B [0.1–1 mM]) at 8 hr postinfection as required and pro-
cessed for immunofluorescence or immunoblot analysis 2–3 hr later
(Arakawa et al., 2007).
Construction of Recombinant A36R-YdF-YFP and YFP-A3L
Vaccinia Virus
The DNA corresponding to the open reading frame of A36R but lacking
the stop codon and 327 bp upstream of the gene (left arm [LA]) was
amplified by PCR using DNA of the viral strain A36R-YdF DNA (ref).
The resulting product was cloned into the HindIII-NotI sites of pBS
SKII containing YFP (in the NotI-BamHI) to generate LA-A36R-YdF-
YFP. In an independent reaction, the DNA corresponding to 325 bp
downstream of the A36R ORF (right arm [RA]) was cloned into the
BamHI-NotI sites of pBS SKII to generate pBS SKII-RA. The LA-
A36R-YdF-YFP insert was subsequently moved into the pBS SKII-RA
using the HindIII-BamHI restriction sites, which flank the insert to gen-
erate the final targeting vector LA-A36R-YdF-YFP-RA in pBS SKII. A
fragment of genomic WR DNA, the 200 bp upstream of A3L, was ampli-
fied by PCR and cloned into the KpnI site of pEL-YFP-A3L to create the
targeting LA-YFP-A3L in pBS SKII. The A36R-YdF-YFP and YFP-A3L
targeting vectors were transfected into DA36R and WR virus-infected
cells, respectively. Recombinant viruses encoding their respective
YFP-tagged proteins were isolated by successive rounds of plaque
purification. The fidelity of the final recombinant virus strains was con-
firmed by sequencing, immunofluorescence, plaque size comparison,
and reinfection assays (Figures S1 and S2).
Generation of YFP-b-Actin Cell Lines
Lentiviruses of YFP-tagged human b-Actin were created using Lentivi-
rus systems (Rubinson et al., 2003). A fragment of pEYFP-b-Actin
(Clontech, CA) was cloned into the NheI-BamHI site of pLL3.7-GFP
to create pLL3.7-EYFP-b-Actin. HeLa cells stably expressing
pEYFP-b-Actin were generated using these lentiviruses and were sub-
sequently isolated by fluorescence-activated cell sorting.
Antibodies, Reagents, and Vector Construction
Antibodies against the viral protein B5R (19C2) (Hiller and Weber,
1985), F13L (Rietdorf et al., 2001), A36R (Ro¨ttger et al., 1999), and
F11L (Valderrama et al., 2006) have been previously described. Anti-
bodies were purchased as follows: Rho (-A, -B, -C) (55) (Upstate,
NY); anti-GST antibody (Sigma-Aldrich, UK); goat Alexa Fluor 488,238 Cell Host & Microbe 1, 227–240, May 2007 ª2007 Elsevier568 conjugates to rabbit, rat, and mouse IgG (Molecular Probes,
OR); goat Cy5 conjugates to rabbit and rat IgG (Jackson Immuno-
Research Laboratories, PA); goat HRP conjugates to rabbit and mouse
IgG (Bio-Rad Laboratories, CA); goat IRDye 800CW conjugates to
mouse IgG (LI-COR Corporate, NE). Alexa Fluor 568-phalloidin (Molec-
ular Probes, OR), TAT-C3 exoenxyme (Sahai and Olson, 2006),
Y-27632 (Calbiochem-Merck Biosciences, Germany), nocodazole,
Latrunculin B, Cytochalasin D, paclitaxel, human plasma fibronectin
(Sigma-Aldrich, UK), Rho Assay Reagents (Upstate, NY), and Jasplaki-
nolide (Molecular Probes, OR, USA). All pEL vectors used in the
manuscript to express proteins during vaccinia infection have been
described previously (Arakawa et al., 2007; Valderrama et al., 2006).
mCherry was provided by R.Y. Tsien (University of California, San
Diego) (Shaner, et al., 2004). mDia1DN3 and ROCK1D3 were provided
by S. Narumiya (Kyoto University, Kyoto, Japan) (Watanabe et al.,
1999; Ishizaki et al., 1997). The vaccinia expression vector pEL-N-
GST-3C was constructed by replacing the GFP with GST-3C in the
pEL vector (Frischknecht et al., 1999). F11L, F11L-V305/K307 (F11L-
VK) were subcloned into the pEL-N-GST-3C vectors.
Analysis of Peripheral Virus Particle Distribution
The number of virus (IEV and CEV) particles within five 4 mm wide rect-
angles up to 4.0 mm or 10.0 mm from the edge of the cell was counted in
fixed cells labeled with the B5R antibody. Peripheral virus particle dis-
tribution was calculated as 0–4 mm and 4–10 mm in ten cells for each
treatment.
Laser Scanning Microscopy and Fluorescence Microscopy
Confocal images from live cells stably expressing YFP-tagged human
b-Actin were collected using a LSM 510 META system with Plan-Apo-
chromat 63/1.40 Oil Ph3 lens (Carl Zeiss MicroImaging, Inc.). To quan-
tify the relative intensity of cortical actin, a confocal slice correspond-
ing to the bottom of the cell was collected at 0, 15, and 30 min after
drug treatment. After background subtraction, five regions of interest
(ROI, 4 3 4 mm square) were randomly placed in the cell periphery.
The relative intensity of cortical actin was calculated as ROI/whole-
cell intensity and showed mean ± SEM in five independent assays.
To analyze IEV movement in the cell periphery, images from live cells
infected with A36R-YdF-YFP strain, which is deficient in actin tail for-
mation, were collected using a Cascade II 512B cooled CCD camera
(Photometrics, AZ) on an Axiovert 200 equipped with a optovar 1.6,
Plan-Apochromat 63/1.40 Oil Ph3 lens (Carl Zeiss, Germany). HeLa
cells were imaged with stream acquisition (50 images in 26 s) at 8 hr
postinfection. Alternatively, cells were imaged at 10 hr postinfection
after transfection with pEL-Cherry expression constructs or addition
of drugs 8 hr after the initial infection. Quantification and analysis of
the behavior of IEV movement in cell periphery was performed using
MetaMorph software (Molecular Devices Corporation, CA). Images
were prepared for publication using Photoshop and Illustrator pack-
ages (Adobe, CA).
Fluorescence-Based Reinfection Assay
To measure the effects of drug addition or protein expression on virus
release at 8 hr postinfection, we developed a fluorescence-based
reinfection assay. HeLa cells in 24-well dishes were infected for 8 hr
with YFP-A3L recombinant virus at an MOI of 5. Infected cells were
washed twice and changed to new media (200 ml) with or without drugs
as necessary. Alternatively, cells were transfected with pEL expression
vectors 8 hr after infection, and new media were added 2 hr later. In
both cases, 12 hr after the addition of new media cells were centri-
fuged and supernatant was removed. To assess virus release, the
supernatant was diluted 200-fold and used to infect cells for 1 hr prior
to agarose overlay for standard plaque assays. The number of fluores-
cent plaques was counted 24 hr later to measure the number of infec-
tious virus particles released into the supernatant from the primary
infection in the various conditions. For each individual experimental
condition, triplicate assays were counted, in at least three independentInc.
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was confirmed by the conventional reinfection assay using WR.
Statistical Analysis
Data are presented as mean ± standard error of the mean and were an-
alyzed by ANOVA or Student’s t test using Prism 4.0 (GraphPad Soft-
ware, CA). A p value of <0.05 was considered statistically significant.
Supplemental Data
The Supplemental Data include two supplemental figures and six sup-
plemental movies and can be found with this article online at http://
www.cellhostandmicrobe.com/cgi/content/full/1/3/227/DC1/.
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